National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 45202 [2014-18233]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
45202
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Notices
toxicological methods and summarizes
recent changes in the vision and
direction of ICCVAM.
• Chapter 2 describes activities of
ICCVAM and the 15 ICCVAM member
agencies relevant to the development
and validation of alternative test
methods for eye safety testing, biologics
and vaccine testing, development of
tests to identify potential skin
sensitizers, and other areas.
• Chapter 3 describes ICCVAM
outreach, communication, and
collaborative activities.
Availability of Report: The report is
available as an electronic PDF document
at https://ntp.niehs.nih.gov/go/iccvambien. All past ICCVAM annual and
biennial reports are also available on
this page.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 15 Federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability, and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and replace,
reduce, or refine (enhance animal wellbeing and lessen or avoid pain and
distress) animal use.
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of NIEHS and provides the
authority for ICCVAM involvement in
activities relevant to the development of
alternative test methods. ICCVAM acts
to ensure that new and revised test
methods are validated to meet the needs
of Federal agencies, increase the
efficiency and effectiveness and Federal
agency test method review, and
optimize utilization of scientific
expertise outside the Federal
Government. Additional information
about ICCVAM can be found at https://
ntp.niehs.nih.gov/go/iccvam.
NICEATM provides support for
ICCVAM and conducts data analyses,
workshops, independent validation
studies, and other activities to assess
new, revised, and alternative test
methods and strategies. NICEATM and
ICCVAM work collaboratively to
evaluate new and improved test
methods and strategies applicable to the
needs of U.S. Federal agencies.
Additional information about NICEATM
can be found at https://ntp.niehs.nih.gov/
go/niceatm.
VerDate Mar<15>2010
17:28 Aug 01, 2014
Jkt 232001
Dated: July 29, 2014.
John R. Bucher,
Associate Director, National Toxicology
Program.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–18239 Filed 8–1–14; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: September 18–19, 2014.
Time: 8:00 a.m. to 4:20 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health
Building 5, Room 127 5 Memorial Drive,
Bethesda, MD 20892.
Contact Person: Michael W. Krause, Ph.D.,
Scientific Director, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institute of Health, Building 5,
Room B104, Bethesda, MD 20892–1818, (301)
402–4633, mwkrause@helix.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: July 28, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–18233 Filed 8–1–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; International Collaborations
in Infectious Diseases Research (U01 & U19).
Date: August 20–22, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring Hotel, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Annie Walker-Abbey,
Scientific Review Officer, Scientific Review
Program, NIAID/NIH/DHHS, 6700B
Rockledge Drive, Rm. 3126, MSC–7616,
Bethesda, MD 20892–7616, 301–451–2671,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: July 30, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–18325 Filed 8–1–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 79, Number 149 (Monday, August 4, 2014)]
[Notices]
[Page 45202]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18233]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: September 18-19, 2014.
Time: 8:00 a.m. to 4:20 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health Building 5, Room 127 5
Memorial Drive, Bethesda, MD 20892.
Contact Person: Michael W. Krause, Ph.D., Scientific Director,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institute of Health, Building 5, Room B104, Bethesda, MD
20892-1818, (301) 402-4633, mwkrause@helix.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: July 28, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18233 Filed 8-1-14; 8:45 am]
BILLING CODE 4140-01-P
